Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
Clasificación en acciones #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Precio por acción
$0.26
Última sincronización: 2024-03-11
Capitalización bursátil
$356.29K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio InVivo Therapeutics Holdings Corporation (NVIV)

Categoría

Ratio P/S de InVivo Therapeutics Holdings Corporation (NVIV)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de InVivo Therapeutics Holdings Corporation, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de InVivo Therapeutics Holdings Corporation desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE